UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. __________)*
NATURAL HEALTH TRENDS CORP.
(NAME OF ISSUER)
Common Stock
(TITLE OF CLASS OF SECURITIES)
63888P109
(CUSIP NUMBER)
February 19, 1999
(DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed' for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 4 pages
<PAGE>
CUSIP No. 63888P109
- --------------------------------------------------------------------------------
1. Name of Reporting Persons
Edward Quinn and Doreen Quinn
I.R.S. Identification Nos. of above persons (entities only).
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) N/A..............................................|_|
(b) .......................................................|_|
- --------------------------------------------------------------------------------
3. SEC Use Only .................................................
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization U.S.A.................
- --------------------------------------------------------------------------------
Number of 5. Sole Voting Power 0..................
Shares Bene- 6. Shared Voting Power 500,000............
ficially Owned 7. Sole Dispositive Power 0..................
by Each 8. Shares Dispositive Power 500,000............
Reporting Person
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
500,000.......................................................
10. Check if the Aggregate Amount in Row (11) Excludes Certain
Shares (See instructions) N/A...........................
11. Percent of Class Represented by Amount in Row (11) 8.02%.....
- --------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) IN
- --------------------------------------------------------------------------------
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
- --------------------------------------------------------------------------------
Page 2 of 4 pages
<PAGE>
ITEM 1.
(a) Name of Issuer
NATURAL HEALTH TRENDS CORP.
(b) Address of Issuer's Principal Executive Offices
250 Park Avenue, New York, NY 10117
ITEM 2.
(a) Name of Person Filing
EDWARD and DOREEN QUINN
(b) Address of Principal Business Office or, if none, Residence
61 Forest Street, Berkley, Massachusetts 02779
(c) Citizenship
U.S.A.
(d) Title of Class of Securities
Common Stock
(e) CUSIP Number: 63888P109
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTIONS 240.13D-1(B) OR
240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:
N/A
ITEM 4. OWNERSHIP
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 500,000
(b) Percent of class: 8.02%
(c) Number of shares as to which the person has:
1. Sole power to vote or to direct the vote: 0
2. Shared power to vote or to direct the vote: 500,000
3. Sole power to dispose or to direct the disposition of: 0
4. Shared power to dispose or to direct the disposition of:
500,000
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
N/A
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
N/A
Page 3 of 4 pages
<PAGE>
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
N/A
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
N/A
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
N/A
ITEM 10. CERTIFICATION
(a) The following certification shall be included if the statement
is filed pursuant to Section 240.13d-1(b).
(b) By signing below I certify that to the best of my knowledge
and belief, the securities referred to above were acquired and
are held in the ordinary course of business and were not
acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
(c) The following certification shall be included if the statement
is filed pursuant to Section 240.ad3-1(c):
By signing below I certify that to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge an belief, I
certify that the information set forth in this statement is true, complete and
correct.
April 13, 1999 April 13, 1999
- ------------------------------- --------------------------------
Date Date
S/ S/
- ------------------------------- --------------------------------
Signature Signature
EDWARD QUINN DOREEN QUINN
- ------------------------------- --------------------------------
Name and Title Name and Title
The original statement shall be signed by each person on whose behalf
the statement is filed or his authorized representative. If the statement is
singed on behalf of a person by his authorized representative other than an
executive officer or general partner of the filing person, evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement provided, however, that a power of attorney for this purpose which
is already on file with the Commission may be incorporated by reference. The
same and any title of each person who signs the statement shall be typed or
printed beneath his signature.
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties for whom copies are to be sent.
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001)
Page 4 of 4 pages
